查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1826776

2025年内视镜逆行性造影（ERCP）全球市场报告

Endoscopic Retrograde Cholangiopancreatography (ERCP) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，内视镜逆行性造影(ERCP) 市场呈现强劲成长势头，市场规模将从 2024 年的 17.2 亿美元成长至 2025 年的 18.6 亿美元，复合年增长率达 8.4%。过去的成长主要归因于各种慢性胃肠道疾病盛行率的上升、ERCP 应用的增加、胰臟癌发病率的上升、政府投资的增加以及医疗旅游业的蓬勃发展。

预计未来几年内视镜逆行性造影(ERCP) 市场规模将强劲成长，到 2029 年将达到 25.8 亿美元，复合年增长率为 8.5%。预测期内的成长可归因于胃肠道疾病盛行率的上升、癌症发生率的上升、投资重点的增加、胰管疾病发生率的上升以及对内视镜需求的不断增长。预测期内的主要趋势包括技术进步、研发伙伴关係、医疗基础设施的扩展、政府医疗保健的扩大以及先进产品的开发。

内视镜逆行性造影(ERCP) 是一种结合 X 光影像和内视镜检查的诊断和治疗性医疗程序，用于治疗胆管、胆囊和胰臟疾病。内视镜检查是指将一根带灯的挠性导管（内视镜）经由口腔插入小肠，以诊断和治疗阻塞和结石等问题。

ERCP 使用的关键产品包括内视镜、内视镜治疗设备、视觉化系统和能量设备。内视镜是一种配有灯和摄影机的柔性管，可让医疗保健专业人员在 ERCP 等手术过程中观察内部器官，尤其是消化道。此手术可治疗多种疾病，包括胃食道逆流症 (GERD)、消化道癌、巴瑞特氏食道症、胆道克隆氏症、消化性溃疡、克隆氏症、肠阻塞和奥格尔维症候群。 ERCP 应用包括胆道括约肌切开术、胆道扩张、胆道置入术、胰臟括约肌切开术、胰管扩张和胰管支架置入术。主要最终使用者是医院、诊所、门诊手术中心和其他医疗机构。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗保健领域产生了重大影响，尤其是对基本医疗设备、诊断设备和药品的供应。医院和医疗机构正疲于应对进口手术器械、诊断影像系统以及注射器和导管等消耗品不断上涨的成本，而这些产品中的许多在国内的替代品有限。由于这些不断上涨的成本给医疗保健预算带来压力，一些医疗机构正在推迟设备升级或将增加的费用转嫁给患者。此外，原料和零件的关税扰乱了关键药品和医疗设备的生产，导致供应链延迟。作为应对措施，该行业正在采用多样化的筹资策略，尽可能扩大本地生产，并游说对关键医疗产品免关税。

本研究报告隶属于商业研究公司 (The Business Research Company) 的新报告系列，提供您在内镜逆行胰造影(ERCP) 行业取得成功所需的数据，包括全球市场规模、区域份额、竞争对手的内视镜逆行胰胆管造影(ERCP) 市场份额、详细的内视镜逆行性造影(ERCP) 市场细分市场和市场市场。本内视镜逆行性造影(ERCP) 市场研究报告提供了完整的产业观点，并对造影和未来情势进行了详细分析。

未来五年预测成长率为8.5%，较先前的预测略有下降0.1%。这一下降主要源自于美国与其他国家之间关税的影响。预计关税壁垒将阻碍美国市场的发展，导致来自美国和中国的内视镜逆行造影(ERCP)导管导引线和胆道支架的成本上升，延长胆道阻塞的治疗时间，并增加介入性胃肠病学的费用。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，关税壁垒的影响也将更加广泛。

胃肠道疾病的盛行率不断上升，预计将推动内视镜逆行性造影(ERCP) 市场的成长。这些疾病涵盖影响胃肠道 (GI) 的各种状况，包括口腔、食道、胃、肠、直肠、肛门、肝臟、胆囊、胰臟和其他附属器官。饮食变化、老化、抗生素使用、生活习惯和环境影响等因素正在增加这些疾病的发生率。 ERCP 是一种微创解决方案，用于诊断和治疗胆汁和胰管问题，例如胆结石、狭窄、肿瘤和感染疾病。例如，美国癌症协会估计，到 2024 年 1 月，美国将新增约 26,890 例胃癌病例，导致约 10,880 人死亡。随着胃肠道疾病变得越来越普遍，对 ERCP 手术的需求也越来越大。

内视镜逆行性胰胆管摄影 (ERCP) 市场中的公司正在透过开发胆管镜系统等创新技术来推进该手术，以增强诊断和治疗效果。这些系统可提供胆管和胰管的高解析度影像，进而改善治疗效果。 2024 年 7 月，Penlon Limited 推出了 VedVision 胆管镜直接视觉化系统，这是一款尖端设备，可为 ERCP 手术提供精确的影像。该系统配备 2 毫米附件通道和专用导管导引线通道，并配有切片检查钳、取石篮、细胞学刷和息肉切除勒除器等配件，从而增强了诊断和治疗能力。

2022年10月，美国半导体製造商豪威科技公司（OmniVision Technologies Inc.）与AdaptivEndo LLC合作，开发了一个用于混合内视镜和一次性内视镜的统一平台。该平台旨在用于胃肠病学、肝病学、泌尿系统和妇科等多种医学专科，并将简化内视镜逆行性造影（ERCP）等内视镜操作。总部位于美国的AdaptivEndo LLC专注于生产结合超音波（EUS）和ERCP功能的一次性内视镜设备，以提高临床的多功能性和效率。

内视镜逆行性造影(ERCP) 市场由提供诊断服务、治疗服务、术后照护和后续照护等服务的营业单位所获得的收益所构成。市场规模还包括服务提供者销售的或包含在其服务产品中的相关产品的价值。内视镜逆行性造影(ERCP) 市场还包括胆道支架、导管导引线和导管的销售。该市场中的商品价值是“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球内视镜逆行性胰造影(ERCP)：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球内视镜逆行性造影（ERCP）市场：成长率分析
  • 全球内视镜逆行性造影(ERCP) 市场表现：规模与成长，2019-2024 年
  • 全球内视镜逆行性造影(ERCP) 市场预测：2024-2029 年、2034 年规模与成长
  • 全球内视镜逆行性胰造影（ERCP）：总目标市场（TAM）

第六章 市场细分

  • 全球内视镜逆行性造影(ERCP) 市场（依产品、效能及预测），2019-2024 年、2024-2029 年、2034 年
  • 内视镜检查
  • 内视镜治疗装置
  • 视觉化系统
  • 能源设备
  • 全球内视镜逆行性造影(ERCP) 市场（依疾病适应症、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 胃食道逆流症（GERD）
  • 消化系统癌症
  • 巴瑞特氏食道症
  • 胆管疾病
  • 消化性溃疡
  • 克隆氏症
  • 肠假性阻塞
  • 奥格尔维综合症
  • 其他的
  • 全球内视镜逆行性造影(ERCP) 市场应用、绩效及预测（2019-2024 年、2024-2029 年、2034 年）
  • 胆道括约肌切开术
  • 胆道扩张
  • 胆道支架置入术
  • 胰臟括约肌切开术
  • 胰管扩张
  • 胰管支架置入术
  • 其他的
  • 全球内视镜逆行性造影(ERCP) 市场（依最终使用者、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 门诊手术中心
  • 其他的
  • 全球内视镜逆行性造影(ERCP) 市场：内视镜细分市场、类型、效能与预测（2019-2024 年、2024-2029 年、2034 年）
  • 柔性内视镜
  • 半硬式内视镜
  • 高解析度内视镜
  • 全球内视镜逆行性造影(ERCP) 市场：内视镜治疗设备细分，依类型、性能及预测，2019-2024 年、2024-2029 年、2034 年
  • 去石装置
  • 球囊扩张导管
  • 支架
  • 切片检查
  • 全球内视镜逆行性造影(ERCP) 市场：视觉化系统细分，依类型、效能与预测，2019-2024 年、2024-2029 年、2034 年
  • 高解析度视觉化系统
  • 内视镜成像系统
  • 影像内视镜
  • 全球内视镜逆行性造影(ERCP) 市场：能量设备细分、按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 电外科设备
  • 雷射设备
  • 氩离子凝固系统

第七章 区域和国家分析

  • 全球内视镜逆行性造影(ERCP) 市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球内视镜逆行性造影(ERCP) 市场（依国家/地区、绩效及预测）2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 内视镜逆行性胰造影（ERCP）市场：竞争格局
  • 内视镜逆行性造影（ERCP）市场：公司简介
    • Medtronic plc
    • Fujifilm Holdings Corporation
    • Siemens Healthineers AG
    • Stryker Corporation
    • Boston Scientific Corporation

第31章：其他领先和创新企业

  • B. Braun Melsungen AG
  • Olympus Corporation
  • Ottomed Endoscopy
  • WL Gore & Associates Inc.
  • Streis plc
  • Cook Group
  • KARL STORZ SE & Co. KG
  • CONMED Corporation
  • PENTAX Medical Inc.
  • AMBU Inc.
  • Samsung Medison Co. Ltd.
  • Medi-Globe GmbH
  • Telemed System Inc.
  • Micro-Tech Endoscopy Inc.
  • Hobbs Medical Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年内视镜逆行性造影(ERCP) 市场：提供新机会的国家
  • 2029年内视镜逆行性胰造影（ERCP）市场：细分领域带来新机会
  • 内视镜逆行性造影(ERCP) 市场 2029 年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r33700u

Endoscopic retrograde cholangiopancreatography (ERCP) is a diagnostic and therapeutic medical procedure that integrates endoscopy with X-ray imaging to address conditions affecting the bile ducts, gallbladder, and pancreas. The process involves inserting a flexible, illuminated tube (endoscope) through the mouth into the small intestine, enabling physicians to diagnose and treat issues such as blockages or stones.

The primary products used in ERCP include endoscopes, endotherapy devices, visualization systems, and energy devices. Endoscopes are flexible tubes with a light and camera, allowing healthcare professionals to visualize the internal organs, particularly the digestive tract, during procedures such as ERCP. The procedure addresses various disease indications, including gastroesophageal reflux disease (GERD), gastrointestinal cancer, Barrett's esophagus, bile duct diseases, peptic ulcer disease, Crohn's disease, intestinal pseudo-obstruction, Ogilvie syndrome, and others. ERCP applications include biliary sphincterotomy, biliary dilatation, biliary stenting, pancreatic sphincterotomy, pancreatic duct dilatation, and pancreatic duct stenting. The key end users are hospitals and clinics, ambulatory surgery centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The endoscopic retrograde cholangiopancreatography (ERCP) market research report is one of a series of new reports from The Business Research Company that provides endoscopic retrograde cholangiopancreatography (ERCP) market statistics, including endoscopic retrograde cholangiopancreatography (ERCP) industry global market size, regional shares, competitors with endoscopic retrograde cholangiopancreatography (ERCP) market share, detailed endoscopic retrograde cholangiopancreatography (ERCP) market segments, market trends and opportunities, and any further data you may need to thrive in the endoscopic retrograde cholangiopancreatography (ERCP) industry. This endoscopic retrograde cholangiopancreatography (ERCP) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endoscopic retrograde cholangiopancreatography (ercp) market size has grown strongly in recent years. It will grow from $1.72 billion in 2024 to $1.86 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to the rising prevalence of various chronic gastrointestinal diseases, rising application of ERCP, rising incidence of pancreatic cancer, rising investments by governments, and the rise in medical tourism.

The endoscopic retrograde cholangiopancreatography (ercp) market size is expected to see strong growth in the next few years. It will grow to $2.58 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to the increasing prevalence of gastrointestinal conditions, rising incidence of cancer, growing focus on investments, increasing incidence of pancreatic duct, and rising demand for endoscopes. Major trends in the forecast period include technological advancements, partnerships for the R&D, expansion of the healthcare infrastructure, expansion of government healthcare, and development of advanced products.

The forecast of 8.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of endoscopic retrograde cholangiopancreatography(ERCP) guidewires and biliary stents sourced from Ireland and China, thereby prolonging biliary obstruction management and elevating interventional gastroenterology costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of gastrointestinal conditions is anticipated to drive the growth of the endoscopic retrograde cholangiopancreatography (ERCP) market. These conditions encompass a wide range of disorders affecting the gastrointestinal (GI) tract, including the mouth, esophagus, stomach, intestines, rectum, anus, and accessory organs such as the liver, gallbladder, and pancreas. Factors such as dietary changes, an aging population, antibiotic use, lifestyle habits, and environmental influences contribute to the increasing incidence of these conditions. ERCP provides a minimally invasive solution for diagnosing and treating bile and pancreatic duct issues, including gallstones, strictures, tumors, and infections. For example, the American Cancer Society estimated in January 2024 that approximately 26,890 new cases of stomach cancer would occur in the United States, with around 10,880 deaths expected. As gastrointestinal conditions become more common, the demand for ERCP procedures continues to grow.

Companies in the ERCP market are advancing procedures by developing innovative technologies, such as cholangioscope systems, for enhanced diagnosis and treatment. These systems provide high-resolution imaging of the bile and pancreatic ducts, improving therapeutic outcomes. In July 2024, Penlon Limited introduced the VedVision Cholangioscope Direct Visualization System, a cutting-edge device offering precise imaging for ERCP procedures. Its features include a 2 mm accessory channel and a dedicated guidewire channel, along with accessories such as biopsy forceps, stone extraction baskets, cytology brushes, and polypectomy snares, enhancing diagnostic and therapeutic capabilities.

In October 2022, OmniVision Technologies Inc., a semiconductor manufacturer based in the United States, collaborated with AdaptivEndo LLC to develop a unified platform for hybrid and single-use endoscopes. This platform is designed for use across various medical specialties, including gastroenterology, hepatology, urology, and gynecology, enabling a more streamlined approach to procedures such as endoscopic retrograde cholangiopancreatography (ERCP) and other endoscopic techniques. AdaptivEndo LLC, also based in the United States, specializes in single-use endoscopy devices that combine the functionalities of endoscopic ultrasound (EUS) and ERCP, offering enhanced versatility and efficiency in clinical practice.

Major players in the endoscopic retrograde cholangiopancreatography (ERCP) market are Medtronic plc, Fujifilm Holdings Corporation, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Ottomed Endoscopy, W. L. Gore & Associates Inc., Streis plc, Cook Group, KARL STORZ SE & Co. KG, CONMED Corporation, PENTAX Medical Inc., AMBU Inc., Samsung Medison Co. Ltd., Medi-Globe GmbH, Telemed System Inc., Micro-Tech Endoscopy Inc., Hobbs Medical Inc., Shaili Endoscopy Pvt. Ltd.

North America was the largest region in the endoscopic retrograde cholangiopancreatography (ERCP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in endoscopic retrograde cholangiopancreatography (ERCP) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the endoscopic retrograde cholangiopancreatography (ERCP) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endoscopic retrograde cholangiopancreatography (ERCP) market consists of revenues earned by entities by providing services such as diagnostic services, therapeutic services, post-operative, and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The endoscopic retrograde cholangiopancreatography (ERCP) market also includes sales of biliary stents, guidewires, and catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endoscopic Retrograde Cholangiopancreatography (ERCP) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endoscopic retrograde cholangiopancreatography (ercp) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endoscopic retrograde cholangiopancreatography (ercp) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The endoscopic retrograde cholangiopancreatography (ercp) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Endoscopes; Endotherapy Devices; Visualization Systems; Energy Devices
  • 2) By Disease Indication: Gastroesophageal Reflux Disease (GERD); Gastrointestinal Cancer; Barrett's Esophagus; Bile Duct Diseases; Peptic Ulcer Disease; Crohn's Disease; Intestinal Pseudo-Obstruction; Ogilvie Syndrome; Other Indications
  • 3) By Application: Biliary Sphincterotomy; Biliary Dilatation; Biliary Stenting; Pancreatic Sphincterotomy; Pancreatic Duct Dilatation; Pancreatic Duct Stentin
  • 4) By End User: Hospitals And Clinics; Ambulatory Surgery Centers; Other End Users
  • Subsegments:
  • 1) By Endoscopes: Flexible Endoscopes; Semi-Rigid Endoscopes; High-Resolution Endoscopes
  • 2) By Endotherapy Devices: Stone Extraction Devices; Balloon Dilatation Catheters; Stents; Biopsy Forceps
  • 3) By Visualization Systems: High-Definition Visualization Systems; Endoscopic Imaging Systems; Video Endoscopes
  • 4) By Energy Devices: Electrosurgical Devices; Laser Devices; Argon Plasma Coagulation Systems
  • Companies Mentioned: Medtronic plc; Fujifilm Holdings Corporation; Siemens Healthineers AG; Stryker Corporation; Boston Scientific Corporation; B. Braun Melsungen AG; Olympus Corporation; Ottomed Endoscopy; W. L. Gore & Associates Inc.; Streis plc; Cook Group; KARL STORZ SE & Co. KG; CONMED Corporation; PENTAX Medical Inc.; AMBU Inc.; Samsung Medison Co. Ltd.; Medi-Globe GmbH; Telemed System Inc.; Micro-Tech Endoscopy Inc.; Hobbs Medical Inc.; Shaili Endoscopy Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Characteristics

3. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Trends And Strategies

4. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Growth Rate Analysis
  • 5.4. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Total Addressable Market (TAM)

6. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Segmentation

  • 6.1. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Endoscopes
  • Endotherapy Devices
  • Visualization Systems
  • Energy Devices
  • 6.2. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gastroesophageal Reflux Disease (GERD)
  • Gastrointestinal Cancer
  • Barrett's Esophagus
  • Bile Duct Diseases
  • Peptic Ulcer Disease
  • Crohn's Disease
  • Intestinal Pseudo-Obstruction
  • Ogilvie Syndrome
  • Other Indications
  • 6.3. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biliary Sphincterotomy
  • Biliary Dilatation
  • Biliary Stenting
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Dilatation
  • Pancreatic Duct Stenting
  • Other Applications
  • 6.4. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Surgery Centers
  • Other End Users
  • 6.5. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Endoscopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Flexible Endoscopes
  • Semi-Rigid Endoscopes
  • High-Resolution Endoscopes
  • 6.6. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Endotherapy Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stone Extraction Devices
  • Balloon Dilatation Catheters
  • Stents
  • Biopsy Forceps
  • 6.7. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Visualization Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-Definition Visualization Systems
  • Endoscopic Imaging Systems
  • Video Endoscopes
  • 6.8. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Sub-Segmentation Of Energy Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electrosurgical Devices
  • Laser Devices
  • Argon Plasma Coagulation Systems

7. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Regional And Country Analysis

  • 7.1. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 8.1. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 9.1. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 9.2. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 10.1. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 11.1. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 11.2. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 12.1. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 13.1. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 14.1. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 14.2. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 15.1. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 15.2. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 16.1. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 17.1. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 18.1. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 19.1. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 20.1. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 21.1. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 21.2. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 22.1. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 23.1. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 23.2. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 24.1. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 24.2. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 25.1. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 25.2. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 26.1. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 26.2. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 27.1. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 28.1. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 28.2. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

  • 29.1. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Overview
  • 29.2. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Competitive Landscape And Company Profiles

  • 30.1. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Competitive Landscape
  • 30.2. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. Olympus Corporation
  • 31.3. Ottomed Endoscopy
  • 31.4. W. L. Gore & Associates Inc.
  • 31.5. Streis plc
  • 31.6. Cook Group
  • 31.7. KARL STORZ SE & Co. KG
  • 31.8. CONMED Corporation
  • 31.9. PENTAX Medical Inc.
  • 31.10. AMBU Inc.
  • 31.11. Samsung Medison Co. Ltd.
  • 31.12. Medi-Globe GmbH
  • 31.13. Telemed System Inc.
  • 31.14. Micro-Tech Endoscopy Inc.
  • 31.15. Hobbs Medical Inc.

32. Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

34. Recent Developments In The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market

35. Endoscopic Retrograde Cholangiopancreatography (ERCP) Market High Potential Countries, Segments and Strategies

  • 35.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer